SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-014880
Filing Date
2021-04-29
Accepted
2021-04-29 09:19:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10022939x2_defa14a.htm DEFA14A 16763
2 image00001.jpg GRAPHIC 15190
3 nc10022939x2_nc1.jpg GRAPHIC 1976795
4 nc10022939x2_nc2.jpg GRAPHIC 1852624
  Complete submission text file 0001140361-21-014880.txt   5168850
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39329 | Film No.: 21867468
SIC: 2834 Pharmaceutical Preparations